Subscribe to Newsletter

Content by Stephanie Vine:

Business & Regulation Business Practice

And a New Era at GSK

| Stephanie Vine

Emma Walmsley is chosen as GlaxoSmithKline's new CEO.

Business & Regulation Business Practice

End of an Era at EFPIA

| Stephanie Vine

Richard Bergstrom has resigned from EFPIA - who will replace him?

Business & Regulation Business Practice

CPhI in Numbers

| Stephanie Vine

Our infographic looks at how the CPhI trade show has grown over the years.

Business & Regulation Business Practice

Public Enemy

| Stephanie Vine

Why is the pharma industry so despised when it has saved countless lives?

Business & Regulation Business Practice

Mylan’s Media Storm

| Stephanie Vine

Mylan introduces new schemes to help tackle EpiPen costs for patients, as well as plans for a new direct-to-patient distribution model

Manufacture Business Practice

The Innovation Awards 2016

| Stephanie Vine

Nominations are open for The Medicine Maker 2016 Innovation Awards.

Manufacture Facilities

Nominations for The Power List 2017

| Stephanie Vine

Nominations for the 2017 Power List are now open and will close on February 1, 2017.

Business & Regulation Facilities

Keep It Clean

| Stephanie Vine

The technology behind cleanrooms is well over 50 years old. Is it time for a makeover?

Manufacture Quality & Compliance

Turning Failure into Success

| Stephanie Vine

We should look to Warning Letters – and the subsequent solutions – to benefit from the blunders of others.

Business & Regulation Business Practice

Big Pharma Ups its Game

| Stephanie Vine, James Strachan

A video game built about the pharma industry adds marketing and malpractice capabilities

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register